Celularity Inc.

NASDAQ: GXGX · Real-Time Price · USD
10.20
2.18 (27.18%)
At close: Jul 19, 2021, 6:00 AM

Celularity Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023
Period Ending Dec 31, 2024 Dec 31, 2023
Revenue
54.22M 22.77M
Cost of Revenue
8.89M n/a
Gross Profit
45.33M n/a
Operating Income
-38.36M -192.29M
Interest Income
331K 320K
Pretax Income
-57.89M -196.28M
Net Income
-57.89M -196.29M
Selling & General & Admin
58.64M 50.58M
Research & Development
17.39M 30.46M
Other Expenses
7.66M 134.02M
Operating Expenses
83.69M 215.06M
Interest Expense
-6.26M -3.02M
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
92.58M n/a
Income Tax Expense
n/a 10K
Shares Outstanding (Basic)
21.89M 188.32M
Shares Outstanding (Diluted)
21.89M 188.32M
EPS (Basic)
-2.64 -11.02
EPS (Diluted)
-2.64 -11.02
EBITDA
-38.36M -192.29M
EBIT
n/a n/a
Depreciation & Amortization
n/a n/a